Showing results (71-80 of 214) with videos related to
Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 17, 2006
Mechanisms of early brain injury after subarachnoid hemorrhageJulian Cahill, W Julian Cahill, John W Calvert, et al.Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.Anti-Cancer Drug Design|March 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituentT R Jones, R F Betteridge, S Neidle, et al.FEBS Letters|March 29, 2000
A family of gamma-like calcium channel subunitsN Klugbauer, S Dai, V Specht, et al.Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.BMC Medical Genetics|May 10, 2015
Pharmacogenetics and the print media: what is the public told?Basima Almomani, Ahmed F Hawwa, Nicola A Goodfellow, et al.Cancer Treatment Reviews|September 1, 1985
Phase I studies with carboplatin at the Royal Marsden HospitalA H Calvert, S J Harland, D R Newell, et al.Pageof 22